Jirakadyarishta, an Ayurvedic formulation prepared by the fermentation of a decoction of Cuminum cyminum (seeds) is traditionally used for intestinal disorders. RP-HPLC analysis of the decoction and the final processed formulation revealed that apigenin-7-O-[galacturonide (1→4)-O-glucoside] and luteolin-4΄-O-glucoside-7-O-galacturonide) were the two major constituents of the decoction of C. cyminum. Selective hydrolysis of 7-O-glucosides of luteolin and apigenin during fermentation resulted in an increase in the amount of luteolin and apigenin. The 4΄-O-glucoside-7-O-galacturonide of luteolin and galacturonide derivative of apigenin were not hydrolyzed during fermentation. Monomeric phenolics, together with 5-hydroxymethyl furfural (5-HMF), were also introduced into the formulation through the jaggery and other plant materials during fermentation. This communication highlights the importance of the ancient processing methods used in Ayurveda.
Jirakadyarishta is one of the ancient liquid oral formulations intended for use in intestinal disorders in the Indian subcontinent. It belongs to the Arishta class of formulations in which the decoction of plant material, along with jaggery, is kept for fermentation. The water soluble constituents predominate in the formulation as the decoction is prepared by continuous boiling of plant material in water for 3-4 hours till the volume is reduced to one-fourth. The ethanol generated during fermentation serves as a preservative [1] . Herbs are generally taken in the form of a decoction in folk medicine. Since the decoction as such cannot be preserved for a long time, the formulation method (for Arishtas) mentions addition of jaggery for preservation and stability. Earlier, we reported an HPLC-DAD analysis of Arjunarishta and Abhayarishta and their standardization by considering the chemical changes occurring as a consequence of the processing method i.e. fermentation [2, 3] .
Cumin seeds used daily in Indian households form the major part of this formulation. Flavonoids (luteolin, apigenin [4] ), their 7-O-glucosides [5] , sesquiterpene lactones (cuminoside A and cuminoside B) [6] and monoterpene glycosides [7] are the reported constituents of the seeds. CCRAS (Central Council for Research in Ayurveda and Siddha), and the Ayurvedic Pharmacopoeia of India (Formulations) provide physicochemical parameters and thin layer chromatography (TLC) profiles of Jirakadyarishta [8, 9] . However, there are no studies on the quantification of major markers and the changes in chemical composition that take place due to fermentation. The present communication highlights the importance of the ancient processing method for the purpose of qualitative and quantitative analysis of Jirakadyarishta. This is the first report of the analysis of the aqueous extract of Cuminum cyminum and its preparation, Jirakadyarishta.
Recent pharmacological reports also support the use of cumin seeds in various intestinal disorders [10, 11] . Aqueous preparations have been shown to have good antioxidant activity in vitro [12] and were found to influence intragastric perfusion in albino rats [13] . Reports on the analysis of cumin seeds are mainly on the volatile oil contents that are considered responsible for the reported biological activities [14, 15] . The mentioned formulation was prepared as per the Ayurvedic Formulary of India [1] . Two brands of marketed preparations were also analyzed for comparison purposes. In addition, the antioxidant property of the decoction and the final processed NPC Natural Product Communications 2010 Vol. 5 No. 11 1767 -1770 formulation were evaluated by the DPPH (diphenyl picryl hydrazine), TBA (thiobarbituric acid), and FTC (ferric thiocyanate) assays.
Selection of marker constituents:
The markers selected for study were based on HPLC analysis of the aqueous extract of cumin seeds. The chromatogram mainly showed the presence of flavonoid glycosides and aglycones (by comparison of UV spectrum). Thus the markers selected for the standardization of the formulation were gallic acid (1) (5) , luteolin (6) apigenin (7), 9-hydroxycuminyl-D-glucoside (8), ellagic acid (9), benzoic acid (10), 5-HMF (11), quercetin (12) and kaempferol (13) . Compound 8 was detected at 241 nm, but all the others at 280 nm.
Method development and validation:
A simultaneous method for the analysis of selected compounds was developed and validated with regard to its specificity, accuracy and precision. The specificity of the developed method was checked by varying the solvent. The limits of detection and quantification were determined by calculating signal-to-noise ratio (S/N) and are shown in Table 1 . The standards were injected at six different concentrations and a value of R 2 >0.999 confirmed the linearity of the method. Table 1 : Linearity, LOD, LOQ, and regression curves of marker. A high repeatability in the concentration of markers in the formulation was observed with RSD % values lower than 4.5 and 4.9% for inter-day and intra-day assays, respectively. The high recovery values (96-104%) obtained indicated satisfactory accuracy of the method (Table 2) . Finally, the robustness of the method was studied by changing the mobile phase. Modifications in the mobile phase (solvent B from 80:20 to 90:10 and 70:30) showed no effect on peak resolution.
Quantification of markers in decoction and formulation:
There was a 4-fold increase in the amount of the flavonoids luteolin (6) and apigenin (7) as compared with the decoction ( Table 3 ). The increase in concentration of the aglycones was due to the selective breakdown of the 7-O-glycosides of luteolin and apigenin during fermentation. The flavonoid galacturonides 2 and 3 were the major constituents of the decoction and formulation. The galacturonide moiety makes the flavonoids more water soluble and hence they are extracted in larger amount than the monoterpene glycosides during boiling. The concentration of galacturonides is slightly (1.5 times) increased in the formulation as compared with the decoction due to its reduced volume (5.2 L to 4.0 L) after fermentation. Unlike flavonoid glycosides, the galacturonides were not hydrolyzed during fermentation. The monomeric phenolics gallic acid (1) and ellagic acid (9) were introduced into the formulation during fermentation through the addition of Woodfordia fruticosa, which is rich in phenolics and hydrolysable tannins; they hydrolyze during fermentation and, therefore, the concentration of monomeric phenolics increases. Similarly, as previously explained, 5-HMF (11) was also introduced during fermentation through Jaggery. 5-HMF (874.2 µg/mL) and ellagic acid (9) (451.6 µg/mL) were quantified using a previous method [3] . The presence of 11 in the Jirakadyarishta is also indicative of the fact that it was introduced in the formulation through jiggery, as it was not seen in the decoction of Jirakadyarishta. The flavonoids quercetin (12) and kaempferol (13) were found in concentrations of 40.2 µg/mL and 66.9 µg/mL, respectively in the formulation. They too are added through W. fruticosa during fermentation, as explained previously [2] . The monoterpene glycoside, 9hydroxycuminyl-D-glucoside (8) was seen in the decoction, but was not detected in the final processed formulation. The absence of 8 in the final processed formulation was suggestive of the fact that it was hydrolyzed during fermentation. As all the volatile oils are lost during boiling, terpene glycosides may be the precursors for the aroma of the formulation. One brand of marketed preparation showed the presence of a high quantity of benzoic acid (994 µg/mL), which may have been used as a preservative in the formulation (Table 3) . 
RP-HPLC-DAD analysis of Jirakadyarishta
Natural Product Communications Vol. 5 (11) 2010 1769 atisara (diarrhea), and grahani (sprue -duodenal disorder). These disorders are mainly related to hemorrhoids (breaking down of capillaries) and their rejuvenation.
There is a risk of infection for which Jirakadyarishta is considered useful. To correlate these disorders the lipid peroxidation activity of the preparation was determined.
The formulation, as well as the decoction, showed high antioxidant activity, as shown in Table 4 . The constituents present in the formulation (aglycones, and galacturonides of flavonoids) have good documented antimicrobial and antioxidant properties and can be thus very useful in the mentioned disorders. In conclusion, the major constituents of the formulation are flavonoid galacturonides and flavonoid aglycones. These compounds are stable in the formulation for a longer period of time and hence they are the markers of the formulation. The flavonoid glycosides undergo hydrolysis during fermentation and were not observed in the formulation. Since, Cuminum cyminum is also used in many other Arishtas, as one of the prakshepa dravya, the results discussed could be useful in defining marker constituents for other formulations containing cumin seeds as an ingredient.
Experimental
General: TLC: Merck silica gel 60 F 254 plates (0.25 mm). TLC visualization was accomplished with a UV lamp (254 and 365 nm) after derivatization with NP reagent. The Shimadzu HPLC system LC-10AVP with PDA and CLASS VP software v. 6 .14 was used in the study. A reversed-phase C-18 column, Luna® (250 mm × 4.6 mm i.d., 5μ) Phenomenex, USA was used for separation. All solvents were of HPLC grade. Methanol (MeOH) was obtained from JT Baker. Water was deionized and purified on an Elga® water purification system. Two marketed formulations of different manufacturers were procured from the local market, Chandigarh, India. Compounds 2-8 were isolated from cumin seeds and characterized by comparison with the data from literature [5] [6] [7] 16, 17] . Compounds 1, 9, and 10-13 were obtained from previous experiments [2, 3] .
Preparation of formulation:
The formulation ingredients mentioned in AFI [1] were accurately weighed and powdered (Cuminum cyminum seeds were passed through a 22-44 # screen. Woodfordia fruticosa (flowers, 313 g) and other prakshepa dravyas (Zingiber officinale, Myristica fragrans, Cyperus rotundus, Cinnamomum zeylanicum, Elettaria cardamomum, Cinnamomum tamala, Mesua ferrea, Trachyspermum ammi, Piper cubeba, and Syzygium aromaticum; each 21.4 g) were passed through a 60 -85 # screen. The decoction (5.2 L) was prepared by boiling C. cyminum seed powder in water (21 L) till the volume was reduced to one fourth of the initial value. Jaggery, W. fruticosa and other prakshepa dravya were added to the decoction in the wooden vat (teak wood) and the mixture was kept at room temperature 25 ± 2°C for one and half months for fermentation. The volume obtained after fermentation of the formulation was 4.0 L.
Sample preparation for HPLC-DAD analysis:
One mL of sample (formulation or decoction) was dried in a rotary evaporator (Buchi) for 30 min to remove the ethanol. Five mL of methanol was then added to the residue, sonicated for 10 mins and centrifuged at 3000 rpm. One mL of supernatant was passed through a 0.45 µm filter (Millipore) and 20 µL was injected for quantification.
Chromatographic conditions:
The gradient method used for analysis was: 
Analytical method validation:
The accuracy of the method was determined by calculating the percentage recovery after spiking the test samples with known quantities of standards. The samples were spiked with 2 different amounts of standards before extraction. The precision of the method was determined by calculating intra-and inter-day variances of the repeated injections of the formulation. Intra-day variance was studied by injecting the same concentration of herbal sample 3 times during the day. Inter-day variance was determined by injecting the same concentration of herbal formulation samples over 5 consecutive days, and standard error of mean and RSD were calculated. Specificity of the method was checked by changing the solvent B (from acetonitrile to methanol). The purity of the peaks was checked by inbuilt software using multivariate analysis (λ = 200-400 nm). Limits of detection and quantification were determined by calculating signal-to-noise ratio. The linearity range of a particular constituent was determined in the range of their concentration in the test samples. All calibration curves were obtained from peak areas of the standard solutions at 6 concentrations, each in triplicate.
Antioxidant activity:
The antioxidant activity of the formulation and decoction were determined according to the published procedure [2] , with some modification in sample preparation for formulation as follows: 50 µL of formulation/decoction was diluted with methanol (4 mL) and centrifuged. One mL of supernatant was further diluted with methanol (3 mL). From the resultant solution, an aliquot of 10, 20, 30, 40, and 50 µL were added to the DPPH solution. In the FTC and TBA assay 50 µL of supernatant was used.
